MD

Michael Dockal

BI Baxalta Incorporated: 15 patents #8 of 230Top 4%
BS Baxter Healthcare Sa: 13 patents #49 of 1,132Top 5%
BI Baxter International: 13 patents #103 of 2,334Top 5%
TL Takeda Pharmaceutical Company Limited: 3 patents #418 of 1,531Top 30%
Overall (All Time): #117,876 of 4,157,543Top 3%
31
Patents All Time

Issued Patents All Time

Showing 25 most recent of 31 patents

Patent #TitleCo-InventorsDate
11793855 TFPI inhibitors and methods of use Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich, Ulrich Reineke +2 more 2023-10-24
11160850 Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders Sabine Knappe, Susanne Till, Peter Turecek, Friedrich Scheiflinger 2021-11-02
11001613 TFPI inhibitors and methods of use Hartmut Ehrlich, Friedrich Scheiflinger, Ulf Reimer, Ulrich Reineke, Thomas Polakowski +1 more 2021-05-11
10822376 Biologically active peptides Friedrich Scheiflinger 2020-11-03
10800816 TFPI inhibitors and methods of use Rudolf Hartmann, Friedrich Scheiflinger, Frank Osterkamp, Thomas Polakowski, Ulrich Reineke 2020-10-13
10287319 Biologically active peptides Friedrich Scheiflinger 2019-05-14
10201586 TFPI inhibitors and methods of use Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich, Ulrich Reineke +2 more 2019-02-12
10124033 Peptides and methods of use Thomas Polakowski, Frank Osterkamp, Rudolf Hartmann, Matthias Paschke, Bettina Hartlieb +1 more 2018-11-13
10036002 Factor X activation Meinhard Hasslacher, Thomas Gatternig, Christian Fiedler, Ernst Böhm, Franziska Horling 2018-07-31
9873720 TFPI inhibitors and methods of use Rudolf Hartmann, Friedrich Scheiflinger, Frank Osterkamp, Thomas Polakowski, Ulrich Reineke 2018-01-23
9873892 Production of fully processed and functional factor X in a furin-secreting mammalian expression system Ernst Böhm, Franziska Horling, Jadranka Koehn 2018-01-23
9777051 TFPI inhibitors and methods of use Hartmut Ehrlich, Friedrich Scheiflinger, Ulf Reimer, Ulrich Reineke, Thomas Polakowski +1 more 2017-10-03
9598464 Biologically active peptides Friedrich Scheiflinger 2017-03-21
9566364 Preparations based on fibrinogen and sulfated polysaccharides Friedrich Scheiflinger, Hans Christian Hedrich, Klaus Tschetschkowitsch, Andreas Goppelt 2017-02-14
9556230 TFPI inhibitors and methods of use Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich, Ulrich Reineke +2 more 2017-01-31
9545436 Methods for treating bleeding disorders using a platelet subpopulation Ernst Böhm, Andrea Sedivy 2017-01-17
9447147 Peptides and methods of use Thomas Polakowski, Frank Osterkamp, Rudolf Hartmann, Matthias Paschke, Bettina Hartlieb +1 more 2016-09-20
9417251 Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides Friedrich Scheiflinger, Zhenqing Zhang, Susanne Till, Sabine Knappe, Christina Szabo 2016-08-16
9206234 Biologically active peptides Friedrich Scheiflinger 2015-12-08
9046536 Methods and compositions for treating bleeding disorders Hartmut Ehrlich, Friedrich Scheiflinger 2015-06-02
9018167 TFPI inhibitors and methods of use Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich, Ulrich Reineke +2 more 2015-04-28
8962563 TFPI inhibitors and methods of use Rudolf Hartmann, Friedrich Scheiflinger, Frank Osterkamp, Thomas Polakowski, Ulrich Reineke 2015-02-24
8822638 Procoagulant peptides Friedrich Scheiflinger 2014-09-02
8632991 Methods and compositions for treating bleeding disorders Hartmut Ehrlich, Friedrich Scheiflinger 2014-01-21
8563688 Procoagulant peptides Friedrich Scheiflinger 2013-10-22